IDH2 and neoplasm: This is due to the accompanied alteration of the methylation profile via the production of 2-hydroxyglutarate (2-HG) by the neomorphic enzymatic function of mutant IDH, which leads to genomic instability and thereby qualifies IDH mutations as tumor-initiating true driver mutations.